Format

Send to:

Choose Destination
See comment in PubMed Commons below
Blood. 2013 Jan 3;121(1):26-8. doi: 10.1182/blood-2012-07-444851.

Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.

Author information

  • 1Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands. b.lowenberg@erasmusmc.nl

Abstract

High-dose cytarabine applied during remission induction or as consolidation after attainment of a complete remission has become an established element in the treatment of adults with acute myeloid leukemia. Recent evidence has challenged the need for these exceptionally high-dose levels of cytarabine. In this review, we present a reappraisal of the usefulness of high-dose cytarabine for acute myeloid leukemia treatment.

PMID:
23287624
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk